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Background.— Despite the prevalence of right ventricular (RV) fail-
ure in congenital heart diseases, cell therapy applied to the right
ventricle is poorly studied. Our aim was to evaluate in a large ani-
mal model of overloaded RV dysfunction such therapy using cardiac
progenitors issued from human embryonic stem cells.
Methods.— A model of combined (barometric and volumetric)
overloaded RV dysfunction was created in piglets using a sur-
gical procedure mimicking repaired tetralogy of Fallot. After
4months, cell therapy was surgically administrated using either
multiple trans-epicardial injections of HUES-24 derived human car-
diac progenitors into right ventricle myocardium or extracellular
matrix hydrogel patches seeded with cardiac progenitors and sewn
after a gentle abrasion on the free wall of the right ventricle.
Myocardial function was measured 3months after cell transplan-
tation by conductance catheter technique using maximal elastance
(Emax) slope. The risk of ventricular arrhythmia was evaluated by
programmed ventricular stimulation at the end of the follow-up. A
histological study analyzed the structural remodelling. The faith of
the progenitors was studied using antibodies directed against Ki67,
CD31, CD34, GFP, Islet1 and Connexin 43. All pigs were immuno-
suppressed using tacrolimus.
Results.— All pigs survived and neither complication nor ventricular
arrhythmia occurred. In injected animals (SHAM group: n = 6, HUES-
24 group: n = 6) the evolution of the Emax slope value was similar
between the two groups. Whereas the total ﬁbrosis increased signif-
icantly with time in SHAM, it returned to baseline values in HUES-24
group. However, the progenitors were not found into myocardium.
In contrast, in patched animals, human progenitors were found not
only in the patch zone, but also close to the myocardium. These
progenitors were able to proliferate, to migrate, to express speciﬁc
cardiac markers and to establish inter-progenitors connexions.
Conclusion.— Cell therapy using trans-myocardial injections of
human cardiac progenitors seems to have a beneﬁcial effect on
overloaded RV tissue remodeling, but this mode of administration
is not sufﬁcient to obtain a signiﬁcant improvement of myocar-
dial contractility. Seeded patch seems to be more conservative for
engrafted cells; their impact on overloaded RV function requires
further experimentation.
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